Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41,168,218
-
Total 13F shares
-
12,800,031
-
Share change
-
-290,562
-
Total reported value
-
$15,871,504
-
Put/Call ratio
-
0.46%
-
Price per share
-
$1.24
-
Number of holders
-
45
-
Value change
-
-$371,477
-
Number of buys
-
10
-
Number of sells
-
21
Institutional Holders of Apyx Medical Corp - Common Stock (APYX) as of Q3 2024
As of 30 Sep 2024,
Apyx Medical Corp - Common Stock (APYX) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,800,031 shares.
The largest 10 holders included
Archon Capital Management LLC, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, HORIZON KINETICS ASSET MANAGEMENT LLC, Taylor Frigon Capital Management LLC, Silverberg Bernstein Capital Management LLC, COMMONWEALTH EQUITY SERVICES, LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, and Private Advisor Group, LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.